ilmofosine has been researched along with Carcinoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Arthur, G; Bittman, R; Byun, HS; Reddy, KC; Samadder, P | 1 |
Berdel, WE; Bicker, U; Boerner, D; Fromm, M; Heim, ME; Herrmann, DB; Neumann, HA | 1 |
1 trial(s) available for ilmofosine and Carcinoma
Article | Year |
---|---|
Phase I trial of the thioether phospholipid analogue BM 41.440 in cancer patients.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Carcinoma; Clinical Trials as Topic; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Organophosphates; Organophosphorus Compounds; Phospholipid Ethers | 1987 |
1 other study(ies) available for ilmofosine and Carcinoma
Article | Year |
---|---|
Enantioselective synthesis and antiproliferative properties of an ilmofosine analog, 2'-(trimethylammonio)ethyl 3-(hexadecyloxy)-2-(methoxymethyl)propyl phosphate, on epithelial cancer cell growth.
Topics: Antineoplastic Agents; Carcinoma; Cell Division; Drug Screening Assays, Antitumor; Humans; Molecular Structure; Phosphatidylcholines; Phospholipid Ethers; Stereoisomerism; Tumor Cells, Cultured | 1997 |